Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:PCSA News 18 December 2025

Processa Pharmaceuticals (PCSA) Stock: Phase 2 Breast Cancer Update, 1-for-25 Reverse Split, and What Wall Street Is Watching on Dec. 18, 2025

Processa Pharmaceuticals (PCSA) Stock: Phase 2 Breast Cancer Update, 1-for-25 Reverse Split, and What Wall Street Is Watching on Dec. 18, 2025

Processa Pharmaceuticals reported preliminary Phase 2 data showing its NGC‑Cap regimen increased cancer-killing metabolite exposure and reduced toxic byproducts in metastatic breast cancer patients. The company also enacted a 1-for-25 reverse stock split effective Dec. 16. Shares saw heavy trading following the announcements.
18 December 2025
·

Stock Market Today

Keppel stock price in focus as broker lifts target and dividend clock ticks

Keppel stock price in focus as broker lifts target and dividend clock ticks

8 February 2026
Keppel shares closed at S$11.64 on Friday, up 0.17%, outperforming the Straits Times Index. UOB Kay Hian raised its target price to S$13.23 after Keppel announced a 38% higher FY2025 dividend, with key dates set for April. The M1 sale remains delayed pending regulatory approval. Investors await updates on asset sales and dividend plans when trading resumes Monday.
DBS share price: DBS Group Holdings stock in focus before Feb 9 earnings

DBS share price: DBS Group Holdings stock in focus before Feb 9 earnings

8 February 2026
DBS closed at S$59.30 on Friday, down 0.6%, ahead of its full-year results due before market open on Feb. 9. Singapore shares fell 0.8% the same day as regional markets slid. Investors await updates on DBS’s margins and capital return plan. Singapore’s Budget 2026 is set for Feb. 12, with UOB and OCBC results later this month.
Go toTop